mannatech - MTEX

MTEX

Close Chg Chg %
8.00 -0.44 -5.50%

Closed Market

7.56

-0.44 (5.50%)

Volume: 8.08K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Company Overview: mannatech - MTEX

MTEX Key Data

Open

$8.16

Day Range

7.56 - 8.25

52 Week Range

7.50 - 16.20

Market Cap

$15.42M

Shares Outstanding

1.90M

Public Float

956.15K

Beta

0.83

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.86

Yield

0.00%

Dividend

$0.20

EX-DIVIDEND DATE

Jun 14, 2023

SHORT INTEREST

N/A

AVERAGE VOLUME

3.65K

 

MTEX Performance

1 Week
 
-3.33%
 
1 Month
 
-16.75%
 
3 Months
 
-5.54%
 
1 Year
 
-28.73%
 
5 Years
 
-56.20%
 

MTEX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About mannatech - MTEX

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

MTEX At a Glance

Mannatech, Inc.
1410 Lakeside Parkway
Flower Mound, Texas 75028
Phone 1-972-471-7400 Revenue 117.87M
Industry Pharmaceuticals: Other Net Income 2.49M
Sector Health Technology Employees 189
Fiscal Year-end 12 / 2025
View SEC Filings

MTEX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 10.167
Price to Sales Ratio 0.215
Price to Book Ratio 2.939
Price to Cash Flow Ratio 11.20
Enterprise Value to EBITDA 6.771
Enterprise Value to Sales 0.17
Total Debt to Enterprise Value 0.334

MTEX Efficiency

Revenue/Employee 623,629.63
Income Per Employee 13,174.603
Receivables Turnover 155.907
Total Asset Turnover 2.931

MTEX Liquidity

Current Ratio 1.19
Quick Ratio 0.668
Cash Ratio 0.572

MTEX Profitability

Gross Margin 76.295
Operating Margin 1.212
Pretax Margin 3.173
Net Margin 2.113
Return on Assets 6.191
Return on Equity 26.076
Return on Total Capital 16.267
Return on Invested Capital 17.925

MTEX Capital Structure

Total Debt to Total Equity 77.699
Total Debt to Total Capital 43.725
Total Debt to Total Assets 17.877
Long-Term Debt to Equity 59.856
Long-Term Debt to Total Capital 33.684
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Mannatech - MTEX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
159.76M 137.21M 131.96M 117.87M
Sales Growth
+5.52% -14.12% -3.83% -10.68%
Cost of Goods Sold (COGS) incl D&A
35.87M 34.69M 30.72M 27.94M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.92M 3.50M 3.53M 1.53M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
-4.34% -3.29% -11.44% -9.04%
Gross Income
123.89M 102.52M 101.24M 89.93M
Gross Income Growth
+8.76% -17.25% -1.25% -11.17%
Gross Profit Margin
+77.55% +74.72% +76.72% +76.30%
2021 2022 2023 2024 5-year trend
SG&A Expense
114.84M 102.93M 102.20M 88.50M
Research & Development
1.20M 1.00M 800.00K 700.00K
Other SG&A
113.64M 101.93M 101.40M 87.80M
SGA Growth
+4.96% -10.38% -0.70% -13.41%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
9.05M (405.00K) (964.00K) 1.43M
Non Operating Income/Expense
(157.00K) (74.00K) (166.00K) 2.59M
Non-Operating Interest Income
- 66.00K 88.00K 4.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 279.00K
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - 279.00K
-
Interest Capitalized
- - - -
-
Pretax Income
8.89M (479.00K) (1.13M) 3.74M
Pretax Income Growth
+55.32% -105.39% -135.91% +430.97%
Pretax Margin
+5.57% -0.35% -0.86% +3.17%
Income Tax
(950.00K) 4.01M 1.11M 1.25M
Income Tax - Current - Domestic
(178.00K) 204.00K 195.00K 169.00K
Income Tax - Current - Foreign
956.00K 2.58M 793.00K 1.24M
Income Tax - Deferred - Domestic
- - 8.00K (47.00K)
-
Income Tax - Deferred - Foreign
(1.73M) 1.23M 113.00K (112.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
9.84M (4.49M) (2.24M) 2.49M
Minority Interest Expense
- - - -
-
Net Income
9.84M (4.49M) (2.24M) 2.49M
Net Income Growth
+57.20% -145.62% +50.13% +211.21%
Net Margin Growth
+6.16% -3.27% -1.70% +2.11%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
9.84M (4.49M) (2.24M) 2.49M
Preferred Dividends
- - - -
-
Net Income Available to Common
9.84M (4.49M) (2.24M) 2.49M
EPS (Basic)
4.9457 -2.3471 -1.1999 1.321
EPS (Basic) Growth
+76.55% -147.46% +48.88% +210.09%
Basic Shares Outstanding
1.99M 1.91M 1.87M 1.89M
EPS (Diluted)
4.7136 -2.3471 -1.1999 1.321
EPS (Diluted) Growth
+70.44% -149.79% +48.88% +210.09%
Diluted Shares Outstanding
2.09M 1.91M 1.87M 1.89M
EBITDA
12.97M 3.09M 2.57M 2.96M
EBITDA Growth
+53.97% -76.17% -16.89% +15.38%
EBITDA Margin
+8.12% +2.25% +1.95% +2.51%

Insider Actions for Mannatech - MTEX

Date Name Shares Transaction Value
Jan 7, 2025 J. Stanley Fredrick Director 356,975 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $14.89 per share 5,315,357.75
Jan 7, 2025 Robert A. Toth Director 91,130 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $14.89 per share 1,356,925.70
Jan 7, 2025 Larry A. Jobe Director 57,407 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $14.89 per share 854,790.23
Jan 7, 2025 Kevin Andrew Robbins Director 21,443 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $14.89 per share 319,286.27
Jan 6, 2025 Tyler Rameson Director 301,883 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $14.89 per share 4,495,037.87
Jan 6, 2025 John A. Seifrick Director 8,956 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $14.89 per share 133,354.84

Mannatech in the News